Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors

Thuru, X; Magnez, R; El-Bouazzati, H; Vergoten, G; Quesnel, B; Bailly, C

Bailly, C (通讯作者),Oncowitan, Sci Consulting Off, F-59290 Lille, France.

CANCERS, 2022; 14 (14):

Abstract

Simple Summary Novel pharmacological approaches are needed to improve treatments of advanced cancers, despite the considerable benefit of immunotherap......

Full Text Link